3//SEC Filing
Kynam Global Healthcare Master Fund, LP 3
Accession 0000919574-23-004864
CIK 0001860782other
Filed
Aug 15, 8:00 PM ET
Accepted
Aug 16, 6:41 PM ET
Size
13.1 KB
Accession
0000919574-23-004864
Insider Transaction Report
Form 3
Holdings
- 5,055,697
Common Stock, par value $0.0001 per share
- 5,055,697(indirect: See Footnote)
Common Stock, par value $0.0001 per share
- 5,524,825(indirect: See Footnote)
Common Stock, par value $0.0001 per share
Kynam Fund GP, LLC
10% Owner
Holdings
- 5,524,825(indirect: See Footnote)
Common Stock, par value $0.0001 per share
- 5,055,697
Common Stock, par value $0.0001 per share
- 5,055,697(indirect: See Footnote)
Common Stock, par value $0.0001 per share
Kynam Capital Management GP, LLC
10% Owner
Holdings
- 5,055,697(indirect: See Footnote)
Common Stock, par value $0.0001 per share
- 5,524,825(indirect: See Footnote)
Common Stock, par value $0.0001 per share
- 5,055,697
Common Stock, par value $0.0001 per share
Tang Yue
10% Owner
Holdings
- 5,524,825(indirect: See Footnote)
Common Stock, par value $0.0001 per share
- 5,055,697
Common Stock, par value $0.0001 per share
- 5,055,697(indirect: See Footnote)
Common Stock, par value $0.0001 per share
Footnotes (4)
- [F1]The reported securities are owned directly by Kynam Global Healthcare Master Fund, LP (the "Master Fund"), a private investment fund managed by Kynam Capital Management, LP (the "Adviser"), and separately managed account clients of the Adviser and may be deemed to be indirectly beneficially owned by (i) the Adviser, (ii) Kynam Capital Management GP, LLC (the "Adviser GP"), the general partner of the Adviser and (iii) Yue Tang, the managing member of the Adviser GP. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
- [F2]At the time the Master Fund became a Reporting Person on this Form 3, the Master Fund and separately managed account clients of the Adviser collectively directly owned 5,853,825 shares of Common Stock, par value $0.0001 per share of 2seventy bio, Inc. and the Adviser, the Adviser GP and Yue Tang may have been deemed to indirectly beneficially owned 5,853,825 shares of Common Stock, par value $0.0001 per share of 2seventy bio, Inc. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
- [F3]The reported securities are directly owned by the Master Fund. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
- [F4]The reported securities are owned directly by the Master Fund and may be deemed to be indirectly beneficially owned by Kynam Fund GP, LLC, the general partner of the Master Fund. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
Documents
Issuer
2seventy bio, Inc.
CIK 0001860782
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001990100
Filing Metadata
- Form type
- 3
- Filed
- Aug 15, 8:00 PM ET
- Accepted
- Aug 16, 6:41 PM ET
- Size
- 13.1 KB